Skip to main content
. 2011 Feb 23;18(8):2381–2387. doi: 10.1245/s10434-011-1602-x

Fig. 1.

Fig. 1

Correlation between the expression levels of miR-142-5p identified by miRNA expression profiling and the prognosis of patients with resected pancreatic cancer in the gemcitabine and nongemcitabine groups. The levels of miRNA expression were normalized against RNU6B. High miR-142-5p expression was significantly associated with longer survival times in the gemcitabine group (P = 0.0077), but not in the nongemcitabine group (P = 0.48)